Objective: To assess the sensitivity and specificity of the Gen-Probe(e) PACE() 2 assay, which uses a chemiluminescent labelled single-stranded DNA probe to detect gonococcal ribosomal RNA (rRNA), for the non-cultural detection of rectal and pharyngeal gonorrhoea in homosexual men.
Introduction
The epidemiology of gonorrhoea has changed in recent years with a much greater proportion of infections now acquired by homosexual contact.'2 Rectal and pharyngeal gonorrhoea has also increased in importance as infection at these sites is more common in homosexual men. Rectal gonorrhoea is recognised as an independent risk factor for HIV infection in homosexual men. 34 The prevalence of rectal gonorrhoea in men has also been suggested as a rapid method of estimating the amount of unsafe sexual behaviour5 and as such can be used to assess the effectiveness of health education and prevention programmes in homosexual men. As HIV infection may also be acquired through oro-genital sex6 7 the high levels of pharyngeal gonorrhoea, over 50% recorded in homosexual men in Newcastle' and Edinburgh8 are a cause for concern.
Difficulties in the cultural diagnosis of rectal and pharyngeal gonorrhoea include issues of sensitivity, related to low numbers of organisms, and specificity, due to the occurrence of non-gonococcal neisseriae such as N meningitidis which are frequently isolated from the throat and occasionally from the rectum.9 Non-cultural methods of detecting gonococcal infection should overcome culture-associated problems. The Gen-Probeg PACE( 2 assay uses a chemiluminescent labelled singlestranded DNA probe that is complementary to the ribosomal RNA (rRNA) of the gonococcus: rRNA released from gonococci in the specimen combines with the labelled probe to form a stable DNA:RNA hybrid which is measured objectively in a luminometer. GenProbe has been extensively evaluated using genital specimens and, in general, high sensitivity has been demonstrated with values of 97.1%,10 99 4%,"1 and 100%12 although one recent study reported a sensitivity of 85-9% for endocervical specimens and 91.5% for male urethral specimens."3 A preliminary evaluation of Gen-Probe gave a sensitivity of 80% for pharyngeal and 100% for rectal specimens14 but it was concluded that further studies were needed.
The objective of this study was to assess the sensitivity and specificity of the Gen-Probeg PACE( 2 assay for the non-cultural detection of rectal and pharyngeal gonorrhoea in homosexual men. 
Patients and methods

Gen-Probe assays
The Gen-Probe collection swabs were stored at -20C and tested according to the manufacturer's instructions. Testing was performed over 20 runs each of which included the three negative reference specimens and the positive control supplied with the kit. The assays were read using the Gen-Probe LEADER Luminometer and the results calculated on the basis of the difference between the response in Relative Light Units (RLU) of the specimen and the mean of the negative reference: a specimen is considered Positive if the difference is > % 300 RLU and negative if the difference is less than 300 RLU.
Repeat testing in the case of discrepant results After comparing the Gen-Probe and culture results all discrepancies were re-tested by GenProbe using the original specimen. Repeatedly reactive Gen-Probe specimens from culture negative patients were also tested by the Gen- 009) respectively. There was no difference between the mean RLU value for the 51 probe negative throat cultures yielding meningococci on culture (101) and the 83 cultures from which meningococci were not isolated (97): the mean RLU values for the two throat cultures yielding N perflava and M catarrhalis were 214 and 87 respectively while the single specimen yielding N lactamica gave a value of 164.
Discussion
As the Gen-Probe assay is currently recommended only for urogenital specimens performance data for extra-genital specimens are extremely limited.'014 Our results show that Gen-Probe is comparable in sensitivity to rectal culture but is significantly more sensitive than pharyngeal culture and support the earlier suggestion that Gen-Probe provides an alternative to culture for rectal and pharyngeal infection. '4 The sensitivity of culture is not absolute but ranges from 80-95% 8 and may be even lower if certain pre-poured selective media are used.'9 Therefore in order to avoid under-estimating the sensitivity and specificity we re-tested all of the reactive Gen-Probe specimens with a probe competition assay (PCA) although a recent study'7 found that this was not normally necessary for specimens with RLU values > 1500. We also attempted to use the ligase chain reaction20 to corroborate the Gen-Probe results but the specimens were unsuitable for amplification by this method. If the probe results are compared directly with rectal culture without repeat testing or confirmation of the probe result by PCA the sensitivity, specificity, PPV and NPV was 93.3%, 97.9%, 82.4% and 99.3% respectively. However, after confirmation by PCA Gen-Probe gave a sensitivity, specificity, PPV and NPV of 94. 1%, 100%, 100% and 99.3%: the sensitivity of culture was reduced to 88.2% and the NPV was 98.6%. Comparing probe results directly with pharyngeal culture gave a sensitivity, specificity, PPV and NPV of 69.2%, 93.9%, 50% and 97 4% respectively which increased to 86.4%, 100%, 100%, and 97.9% after confirmation by PCA: the sensitivity of culture was reduced to 59% and the NPV to 93.9%; the difference in sensitivity between culture and Gen-Probe is significant (p < 0.05). The finding that probe positive culture negative pharyngeal results occurred significantly more often (p < 0.001) in patients with culture proven rectal gonorrhoea (26.7%) than in those without rectal infection (3.4%) lends epidemiological support to the accuracy of the probe results. False positive probe results due to organisms such as meningococci sharing rRNA sequences to those on which the probe is based are extremely unlikely as the same probe is used in a culture confirmation assay which had absolute specificity when evaluated in an "in-use"' assay which included a range of non gonococcal neisseriae.2' The finding that GenProbe sensitivity was comparable to rectal culture (p > 0 2) but significantly higher than throat culture (p < 0.05) is in keeping with the significant difference (p = 0.019) in the mean RLU value for rectal (31 325) versus throat specimens (10 447) which indicates a higher antigenic load in the rectal specimens. There were three culture positive Gen-Probe negative pharyngeal specimens compared with one culture positive probe negative rectal specimen which is consistent with sampling differences becoming more important when the number of organisms is low.
It is also possible that Gen-Probe detected non-viable antigen in the pharynx. Serological studies22 have suggested that some patients are exposed to pharyngeal gonorrhoea without developing culture-proven pharyngeal infection. N meningitidis has been reported to have a possible protective effect against genital gonococcal infection23 so it is possible that a similar protective effect may occur in the pharynx. Nevertheless a positive result would appear to indicate exposure to infection and, in the absence of a previously treated infection, could be important in ensuring appropriate partner notification action. There is little information on probe positivity following treatment'0 and further studies are required to monitor the disappearance of gonococcal nucleic acid after therapy.
Our results demonstrating a prevalence of rectal infection of 10-6% for Gen-Probe versus 8.8% for culture and a prevalence of pharyngeal infection of 11.8% for Gen-Probe versus 8 1% for culture provide a baseline by which other centres could use Gen-Probe to evaluate the efficiency of their rectal and pharyngeal cultures. Whenever possible cultures should be obtained from patients with positive probe test results in order to monitor the antibiotic susceptibility and molecular epidemiology of the gonococcal population.
